Evidence map›Paper›PMID 32128419›Full record

ArticleScience advances2020

Sustained IFN-I stimulation impairs MAIT cell responses to bacteria by inducing IL-10 during chronic HIV-1 infection.

X Tang, S Zhang, Q Peng, L Ling, H Shi, Y Liu, L Cheng, L Xu, L Cheng, L A Chakrabarti and 3 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 49 citations in OpenAlex.

  1. Trial
  2. Restoration of HBV-specific CD8Signal transduction and targeted therapy · 2021
    Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Advances in Single-Cell Sequencing for Infectious Diseases: Progress and Perspectives.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. The Emerging Role of MAIT Cell Responses in Viral Infections.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Frontiers in immunology · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 4 countries.

X TangInstitute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen 518112, Guangdong Province, China.ORCID 0000-0003-0235-995X
S ZhangShanghai Public Health Clinical Center and Institute of Biomedical Sciences, Fudan University, Shanghai 201508, China.ORCID 0000-0002-4749-6790
Q PengDepartment of Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen 518112, China.ORCID 0000-0001-6845-7195
L LingAIDS Institute and Department of Microbiology, State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Li Ka Shing Faculty of Medicine, Hong Kong, China.ORCID 0000-0001-6386-9019
H ShiInstitute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen 518112, Guangdong Province, China.ORCID 0000-0002-8616-7869
Y LiuInstitute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen 518112, Guangdong Province, China.
L ChengInstitute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen 518112, Guangdong Province, China.ORCID 0000-0001-8066-527X
L XuDepartment of Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen 518112, China.
L ChengLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
L A ChakrabartiInstitut Pasteur, Groupe Contrôle des Infections Virales Chroniques, Unité Virus et Immunité, 75724 Paris Cedex 15, France.ORCID 0000-0002-1895-3630
Z ChenInstitute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen 518112, Guangdong Province, China.
H WangDepartment of Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen 518112, China.
Z ZhangInstitute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Shenzhen 518112, Guangdong Province, China.ORCID 0000-0002-3544-1389
Shenzhen Third People’s Hospital · CNSouthern University of Science and Technology · CNUniversity of North Carolina at Chapel Hill · USInstitut Pasteur · FRShanghai Public Health Clinical Center · CNUniversity of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mucosal-associated invariant T (MAIT) cells in HIV-1-infected individuals are functionally impaired by poorly understood mechanisms. Single-cell transcriptional and surface protein analyses revealed that peripheral MAIT cells from HIV-1-infected subjects were highly activated with the up-regulation of interferon (IFN)-stimulated genes as compared to healthy individuals. Sustained IFN-α treatment suppressed MAIT cell responses to

Indexed as

Antiretroviral Therapy, Highly ActiveCostimulatory and Inhibitory T-Cell ReceptorsCytokinesEscherichia coliEscherichia coli InfectionsFemaleHIV-1HIV InfectionsHost-Pathogen InteractionsHumansInterferon Type IInterleukin-10Lymphocyte ActivationMaleMucosal-Associated Invariant T CellsSignal TransductionCostimulatory and Inhibitory T-Cell ReceptorsCytokinesIL10 protein, humanInterferon Type IInterleukin-10

Identifiers

PMID32128419
PMCPMC7030930
OpenAlexW3007041284

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.